Hrt Financial LP Charles River Laboratories International, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 14,769 shares of CRL stock, worth $2.41 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,769

Holding current value

$2.41 Million

% of portfolio

0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $2.78 Million - $3.62 Million	14,769 New	14,769 $2.91 Million
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $988,293 - $1.33 Million	4,856 New	4,856 $1.32 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $1.1 Million - $1.26 Million	6,002 Added 35.66%	22,835 $4.8 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $3.23 Million - $4.38 Million	16,833 New	16,833 $3.4 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $2.02 Million - $2.99 Million	9,891 New	9,891 $2.12 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $17.3 Million - $21.9 Million	-58,879 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $496,843 - $595,965	1,990 Added 3.5%	58,879 $17.1 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $4.09 Million - $4.65 Million	18,401 Added 47.81%	56,889 $14.2 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $6.76 Million - $8.72 Million	38,488 New	38,488 $8.72 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $895,459 - $1.09 Million	-7,104 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $888,497 - $1.02 Million	7,104 New	7,104 $940,000

Others Institutions Holding CRL

# of Institutions

692

Shares Held

51.7M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.3B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account